Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody

Platinum chemotherapy remains part of standard therapies in the management of a variety of cancers. Severe side effects and a high degree of resistance to platinum drugs have led numerous researchers to search for predictive biomarkers, which could aid in identifying patients that are the most likel...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, David Hersi, Fiehn, Anne-Marie Kanstrup, Fogh, Louise, Christensen, Ib Jarle, Hansen, Tine Plato, Stenvang, Jan, Nielsen, Hans Jørgen, Nielsen, Kirsten Vang, Hasselby, Jane Preuss, Brünner, Nils, Jensen, Sussie Steen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945488/
https://www.ncbi.nlm.nih.gov/pubmed/24603753
http://dx.doi.org/10.1038/srep04313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945488/
https://www.ncbi.nlm.nih.gov/pubmed/24603753
http://dx.doi.org/10.1038/srep04313

Ejemplares similares